{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:10:28Z","timestamp":1788797428374,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.clinre.2014.06.007","type":"journal-article","created":{"date-parts":[[2014,7,18]],"date-time":"2014-07-18T22:45:50Z","timestamp":1405723550000},"page":"727-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A new model for predicting liver cirrhosis in chronic hepatitis B virus carriers with low serum alanine transaminase activity"],"prefix":"10.1016","volume":"38","author":[{"given":"Da-Wu","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Lian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Ji","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Yong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2014.06.007_bib0005","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","article-title":"Epidemiological serosurvey of hepatitis B in China\u00a0\u2013\u00a0declining HBV prevalence due to hepatitis B vaccination","volume":"27","author":"Liang","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.clinre.2014.06.007_bib0010","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJM200205303462202","article-title":"Chronic hepatitis B","volume":"346","author":"Lok","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2014.06.007_bib0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.7326\/0003-4819-147-1-200707030-00010","article-title":"The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points","volume":"147","author":"Lai","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinre.2014.06.007_bib0020","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12072-008-9080-3","article-title":"Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update","volume":"2","author":"Liaw","year":"2008","journal-title":"Hepatol Int"},{"key":"10.1016\/j.clinre.2014.06.007_bib0025","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0168-8278(02)00004-1","article-title":"Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers","volume":"36","author":"Martinot-Peignoux","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2014.06.007_bib0030","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1053\/jhep.2002.33638","article-title":"Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B","volume":"35","author":"Hsu","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.06.007_bib0035","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1136\/gut.2005.065136","article-title":"Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications","volume":"54","author":"Yuen","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2014.06.007_bib0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis, B., virus, infection","volume":"57","author":"European Association For The Study Of The Liver","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2014.06.007_bib0045","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1002\/hep.22976","article-title":"Evaluation of the patient with hepatitis B","volume":"49","author":"Rotman","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.06.007_bib0050","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0168-8278(03)00171-5","article-title":"Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B","volume":"39","author":"Myers","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2014.06.007_bib0055","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1478-3231.2006.01287.x","article-title":"Non-invasive models for predicting histology in patients with chronic hepatitis B","volume":"26","author":"Wai","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2014.06.007_bib0060","doi-asserted-by":"crossref","first-page":"e23077","DOI":"10.1371\/journal.pone.0023077","article-title":"A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B","volume":"6","author":"Seto","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.clinre.2014.06.007_bib0065","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple non-invasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.06.007_bib0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.06.007_bib0075","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1007\/s10620-010-1477-x","article-title":"Development and validation of a model to predict advanced fibrosis in chronic hepatitis B virus-infected patients with high viral load and normal or minimally raised ALT","volume":"56","author":"Park","year":"2011","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinre.2014.06.007_bib0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2893.1997.00141.x","article-title":"Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups","volume":"4","author":"Poynard","year":"1997","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.clinre.2014.06.007_bib0085","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1478-3231.2008.01784.x","article-title":"Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis","volume":"28","author":"Fung","year":"2008","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2014.06.007_bib0090","first-page":"324","article-title":"The progamme of prevention and cure for virus hepatitis","volume":"8","author":"Chinese Society of Infectious Diseases and Parasitology an dChinese Society of Hepatology of Chinese Medical Association","year":"2000","journal-title":"Zhonghua Ganzangbing Zazhi"},{"key":"10.1016\/j.clinre.2014.06.007_bib0095","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","article-title":"Classification of chronic viral hepatitis: a need for reassessment","volume":"13","author":"Scheuer","year":"1991","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2014.06.007_bib0100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.06.007_bib0105","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1089-3261(02)00009-0","article-title":"Scoring of chronic hepatitis","author":"Scheuer","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinre.2014.06.007_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhep.2008.10.014","article-title":"Liver biopsy: the best, not the gold standard","volume":"50","author":"Bedossa","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2014.06.007_bib0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jhep.2008.07.039","article-title":"Exceeding the limits of liver histology markers","volume":"50","author":"Mehta","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2014.06.007_bib0120","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/hep.20717","article-title":"Comparison and validation of simple non-invasive tests for prediction of fibrosis in chronic hepatitis C","volume":"41","author":"Lackner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.06.007_bib0125","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1586\/17474124.2.4.541","article-title":"Assessing liver fibrosis","volume":"2","author":"Castera","year":"2008","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2014.06.007_bib0130","doi-asserted-by":"crossref","DOI":"10.1097\/MEG.0b013e328363e29d","article-title":"Development and validation of a nomogram based on clinical factors and standard laboratory tests for prediction of clinically significant liver fibrosis in chronic hepatitis C virus infection","author":"Sagrini","year":"2013","journal-title":"Eur J Gastroenterol Hepatol."},{"issue":"10","key":"10.1016\/j.clinre.2014.06.007_bib0135","doi-asserted-by":"crossref","first-page":"e77942","DOI":"10.1371\/journal.pone.0077942","article-title":"Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new non-invasive model for predicting liver fibrosis in HBV-related liver disease","volume":"8","author":"Zeng","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.clinre.2014.06.007_bib0140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1665-2681(19)31854-X","article-title":"Thrombopoietin level in patients with chronic liver diseases","volume":"17","author":"Eissa","year":"2008","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clinre.2014.06.007_bib0145","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1572-0241.2005.41543.x","article-title":"The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis","volume":"100","author":"Rios","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2014.06.007_bib0150","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jhep.2010.08.018","article-title":"Platelet production and destruction in liver cirrhosis","volume":"54","author":"Pradella","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2014.06.007_bib0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2893.2012.01628.x","article-title":"Serum bile acid levels as a predictor for the severity of liver fibrosis in patients with chronic hepatitis C","volume":"20","author":"Shlomai","year":"2013","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.clinre.2014.06.007_bib0160","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11239-009-0330-6","article-title":"Comparison of modes of prothrombin time reporting in patients with advanced liver disease associated with viral hepatitis","volume":"29","author":"Wei","year":"2010","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.clinre.2014.06.007_bib0165","first-page":"746","article-title":"Relation between HBsAg levels during the immune clearance phase of hepatitis B virus infection and liver pathological stages of chronic hepatitis B","volume":"20","author":"Zeng","year":"2012","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.clinre.2014.06.007_bib0170","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jhep.2013.01.028","article-title":"Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naive, e antigen-positive patients","volume":"58","author":"Martinot-Peignoux","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2014.06.007_bib0175","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new non-invasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.clinre.2014.06.007_bib0180","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3109\/00365541003774616","article-title":"The role of the non-invasive serum marker FibroTest-ActiTest in the prediction of histological stage of fibrosis and activity in children with naive chronic hepatitis B infection","volume":"42","author":"Sokucu","year":"2010","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.clinre.2014.06.007_bib0185","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/apt.12307","article-title":"Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus","volume":"37","author":"de L\u00e9dinghen","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2014.06.007_bib0190","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-230X-7-40","article-title":"Meta-analyses of FibroTest diagnostic value in chronic liver disease","volume":"7","author":"Poynard","year":"2007","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clinre.2014.06.007_bib0195","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-230X-12-14","article-title":"Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis","volume":"12","author":"Jin","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clinre.2014.06.007_bib0200","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1111\/jvh.12010","article-title":"Comparison of FIB-4 and APRI in Chinese HBV-infected patients with persistently normal ALT and mildly elevated ALT","volume":"20","author":"Wang","year":"2013","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.clinre.2014.06.007_bib0205","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/hep.20960","article-title":"Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a non-invasive model","volume":"42","author":"Zeng","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.06.007_bib0210","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1478-3231.2007.01519.x","article-title":"Non-invasive models to predict liver cirrhosis in patients with chronic hepatitis B","volume":"27","author":"Kim","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.clinre.2014.06.007_bib0215","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/jhep.2002.36128","article-title":"Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model","volume":"36","author":"Forns","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2014.06.007_bib0220","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1572-0241.2005.41289.x","article-title":"Identification of chronic hepatitis B patients without significant liver fibrosis by a simple non-invasive predictive model","volume":"100","author":"Hui","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2014.06.007_bib0225","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1373\/clinchem.2007.097923","article-title":"How to measure the diagnostic accuracy of non-invasive liver fibrosis indices: the area under the ROC curve revisited","volume":"54","author":"Lambert","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinre.2014.06.007_bib0230","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1373\/clinchem.2007.085795","article-title":"Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages","volume":"53","author":"Poynard","year":"2007","journal-title":"Clin Chem"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740114001521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740114001521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T15:38:46Z","timestamp":1788795526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740114001521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S2210740114001521"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2014.06.007","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new model for predicting liver cirrhosis in chronic hepatitis B virus carriers with low serum alanine transaminase activity","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2014.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown copyright \u00a9 2014 Published by Elsevier Masson SAS All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}